Shockwave Medical completed the acquisition of Neovasc for $107m.

Shockwave Medical, a medical device company, completed the acquisition of Neovasc, a specialty medical device company, for $107m. “The timing is ideal as there will be no distraction to our US sales organization in the near term and, as we did with C2, our coronary device, we expect to refine our commercialization approach and begin the development of international markets in advance of US approval. This transaction supports our commitment to drive growth through innovation and we are excited for the potential to bring even more solutions to our customers and the patients they serve with the Reducer System," Doug Godshall, Shockwave President and CEO.